Search

Your search keyword '"Viotti, Valeria"' showing total 2 results
Start Over Author "Viotti, Valeria" Topic patient involvement
2 results on '"Viotti, Valeria"'

1. The alliance between genetic biobanks and patient organisations: the experience of the telethon network of genetic biobanks.

Author

Baldo, Chiara, Casareto, Lorena, Renieri, Alessandra, Merla, Giuseppe, Garavaglia, Barbara, Goldwurm, Stefano, Pegoraro, Elena, Moggio, Maurizio, Mora, Marina, Politano, Luisa, Sangiorgi, Luca, Mazzotti, Raffaella, Viotti, Valeria, Meloni, Ilaria, Pellico, Maria Teresa, Barzaghi, Chiara, Wang, Chiuhui Mary, Monaco, Lucia, and Filocamo, Mirella

Subjects
GENE libraries, TELETHONS, PATIENTS' associations, MEDICAL research, DRUG development
Abstract

Background: Rare diseases (RDs) are often neglected because they affect a small percentage of the population (6-8%), which makes research and development of new therapies challenging processes. Easy access to high-quality samples and associated clinical data is therefore a key prerequisite for biomedical research. In this context, Genetic Biobanks are critical to developing basic, translational and clinical research on RDs. The Telethon Network of Genetic Biobanks (TNGB) is aware of the importance of biobanking as a service for patients and has started a dialogue with RD-Patient Organisations via promotion of dedicated meetings and round-tables, as well as by including their representatives on the TNGB Advisory Board. This has enabled the active involvement of POs in drafting biobank policies and procedures, including those concerning ethical issues. Here, we report on our experience with RD-Patient Organisations who have requested the services of existing biobanks belonging to TNGB and describe how these relationships were established, formalised and maintained. Results: The process of patient engagement has proven to be successful both for lay members, who increased their understanding of the complex processes of biobanking, and for professionals, who gained awareness of the needs and expectations of the people involved. This collaboration has resulted in a real interest on the part of Patient Organisations in the biobanking service, which has led to 13 written agreements designed to formalise this process. These agreements enabled the centralisation of rare genetic disease biospecimens and their related data, thus making them available to the scientific community. Conclusions: The TNGB experience has proven to be an example of good practice with regard to patient engagement in biobanking and may serve as a model of collaboration between disease-oriented Biobanks and Patient Organisations. Such collaboration serves to enhance awareness and trust and to encourage the scientific community to address research on RDs. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

2. The alliance between genetic biobanks and patient organisations: the experience of the telethon network of genetic biobanks

Author

Maria Teresa Pellico, Luca Sangiorgi, Marina Mora, Stefano Goldwurm, Raffaella Mazzotti, Mirella Filocamo, Chiuhui Mary Wang, Chiara Barzaghi, Elena Pegoraro, Luisa Politano, Valeria Viotti, Maurizio Moggio, Alessandra Renieri, Lucia Monaco, Giuseppe Merla, C. Baldo, Ilaria Meloni, Lorena Casareto, Barbara Garavaglia, Baldo, Chiara, Casareto, Lorena, Renieri, Alessandra, Merla, Giuseppe, Garavaglia, Barbara, Goldwurm, Stefano, Pegoraro, Elena, Moggio, Maurizio, Mora, Marina, Politano, Luisa, Sangiorgi, Luca, Mazzotti, Raffaella, Viotti, Valeria, Meloni, Ilaria, Pellico, Maria Teresa, Barzaghi, Chiara, Wang, Chiuhui Mary, Monaco, Lucia, Filocamo, Mirella, Baldo, C, Casareto, L, Renieri, A, Merla, G, Garavaglia, B, Goldwurm, S, Pegoraro, E, Moggio, M, Mora, M, Politano, L, Sangiorgi, L, Mazzotti, R, Viotti, V, Meloni, I, Pellico, Mt, Barzaghi, C, Wang, Cm, Monaco, L, and Filocamo, M

Subjects
0301 basic medicine, Centralisation, Biobanking, Service (systems architecture), Biomedical Research, Process (engineering), media_common.quotation_subject, Population, Patient organisations, lcsh:Medicine, Context (language use), 030105 genetics & heredity, Agreement, 03 medical and health sciences, Networking, Promotion (rank), Agreements, Patient involvement, Rare diseases, Research, Sample and data centralisation, Medicine (all), Genetics (clinical), Pharmacology (medical), Humans, Genetics(clinical), education, Biological Specimen Banks, media_common, Medicine(all), education.field_of_study, business.industry, lcsh:R, General Medicine, Public relations, Biobank, 030104 developmental biology, Alliance, Patient organisation, business, Rare disease
Abstract

Background Rare diseases (RDs) are often neglected because they affect a small percentage of the population (6–8 %), which makes research and development of new therapies challenging processes. Easy access to high-quality samples and associated clinical data is therefore a key prerequisite for biomedical research. In this context, Genetic Biobanks are critical to developing basic, translational and clinical research on RDs. The Telethon Network of Genetic Biobanks (TNGB) is aware of the importance of biobanking as a service for patients and has started a dialogue with RD-Patient Organisations via promotion of dedicated meetings and round-tables, as well as by including their representatives on the TNGB Advisory Board. This has enabled the active involvement of POs in drafting biobank policies and procedures, including those concerning ethical issues. Here, we report on our experience with RD-Patient Organisations who have requested the services of existing biobanks belonging to TNGB and describe how these relationships were established, formalised and maintained. Results The process of patient engagement has proven to be successful both for lay members, who increased their understanding of the complex processes of biobanking, and for professionals, who gained awareness of the needs and expectations of the people involved. This collaboration has resulted in a real interest on the part of Patient Organisations in the biobanking service, which has led to 13 written agreements designed to formalise this process. These agreements enabled the centralisation of rare genetic disease biospecimens and their related data, thus making them available to the scientific community. Conclusions The TNGB experience has proven to be an example of good practice with regard to patient engagement in biobanking and may serve as a model of collaboration between disease-oriented Biobanks and Patient Organisations. Such collaboration serves to enhance awareness and trust and to encourage the scientific community to address research on RDs. Electronic supplementary material The online version of this article (doi:10.1186/s13023-016-0527-7) contains supplementary material, which is available to authorized users.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results